GeoVax Advances Mpox Vaccine Development Amid Rising Global Cases
GeoVax Labs, Inc., a clinical-stage biotechnology company, is making significant strides in the development of its GEO-MVA vaccine for Mpox and smallpox, addressing the urgent need for diversified vaccine options amidst rising global cases. The company has received favorable regulatory feedback from the European Medicines Agency (EMA), setting the stage for an expedited path toward […]